Results of a randomised, placebo-controlled 6-month study of memantine in the treatment of mild to moderate Alzheimer's disease in Europe

被引：0

作者：

Bakchine, S

Pascual-Gangnant, L

Hefting, N

Loft, H

机构：

[1] Reims Univ Hosp, Maison Blanche Hosp, Reims, France

[2] Lundbeck SA, Int Clin Sci, Paris, France

[3] H Lundbeck & Co AS, Int Clin Sci, Valby, Denmark

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2005年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S567 / S568

页数：2

共 50 条

[1] Results of a randomised, placebo-controlled six-month study of memantine in the treatment of mild to moderate Alzheimer's disease in Europe
Bakchine, S.
Pascual-Gangnant, L.
Loft, H.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 187 - 187
[2] Memantine treatment in patients with mild to moderate Alzheimer's disease: Results of a randomised, double-blind, placebo-controlled 6-month study
Bakchine, S.
Loft, H.
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2008, 13 (01) : 97 - 107
[3] Memantine treatment in patients with mild to moderate Alzheimer's disease: Results of a randomised, double-blind, placebo-controlled 6-month study
Bakchine, S.
Loft, H.
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2007, 11 (04) : 471 - 479
[4] A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with PDD or DLB
Emre, M.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 338 - 338
[5] A 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease
Imbimbo, BP
Troetel, WM
Martelli, P
Lucchelli, F
[J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (01) : 17 - 24
[6] A placebo-controlled study of memantine in advanced Alzheimer's disease.
Reisberg, B
Stoeffler, A
Ferris, S
Schmitt, F
Doody, R
Moebuis, HJ
[J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 90 - 90
[7] Update of memantine safety in 6-month and long-term treatment of mild to severe Alzheimer's disease
Alva, Gustavo
FarloW, Martin R.
Porsteinsson, Anton
Graham, Stephen M.
[J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 141S - 141S
[8] Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: Secondary analyses from a placebo-controlled randomized trial
Pomara, Nunzio
Ott, Brian R.
Peskind, Elaine
Resnick, E. Malca
[J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (01): : 60 - 64
[9] A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease
Winblad, B.
Grossberg, G.
Frolich, L.
Farlow, M.
Zechner, S.
Nagel, J.
Lane, R.
[J]. NEUROLOGY, 2007, 69 : S14 - S22
[10] Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial
Wade, Alan G.
Farmer, Mildred
Harari, Gil
Fund, Naama
Laudon, Moshe
Nir, Tali
Frydman-Marom, Anat
Zisapel, Nava
[J]. CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 947 - 961

← 1 2 3 4 5 →